The Therapeutic Goods Administration (TGA) and Medsafe are seeking comments and input from interested parties on a discussion paper setting out the high level features of a possible framework for regulation of therapeutic products within the ANZTPA-a joint scheme to regulate therapeutic products in Australia and New Zealand. The draft discussion document focuses on the manufacture and approval of medicines, medical devices and blood & blood components biological.
Consultation document in PDF - 372kb
Consultation document in Word - 115kb
NZNO will be making a submission if you wish to provide feedback please send it to Leanne Manson Policy Advisor; firstname.lastname@example.org
Feedback Due: 15 February 2013